Corticosteroid-induced osteoporosis prevention

Longitudinal practice patterns in The Netherlands 2001-2005

M. Duyvendak, M. Naunton, J. Atthobari, P. B. Van Den Berg, J. R.B.J. Brouwers

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Summary: We investigated prevention trends and predictors for osteoporosis prevention in long term corticosteroid users. The use of bisphosphonates increased from 2001 to 2005. Longer duration of corticosteroid use and DMARD use were predictors for receiving prevention. Females appear reasonably well treated; however, men require more attention. Introduction: Previous studies have shown that long-term corticosteroid users are undertreated for osteoporosis prevention. Our aim was to identify prevention trends in long-term corticosteroid users from 2001-2005 in The Netherlands and to identify predictors for bisphosphonate prophylaxis. Methods: Pharmacy dispensing data were used from 9 community pharmacies. All oral corticosteroid doses were converted to "prednisolone equivalents". We then identified long-term (≥90 days) corticosteroid episodes, which required bisphosphonate prophylaxis as per 2002 Dutch guidelines; Multivariate logistic regression was used to identify predictors for receiving prevention. Results: We identified 615 different corticosteroid patients requiring prophylaxis. From 2001-2005 the use of bisphosphonates increased from 38% to 54% (p=0.001). In 2005 females were prescribed more bisphosphonates than males (61% vs. 39%; p=0.002), or any treatment (72% vs. 45%; p<0.001). Multivariate analysis showed that longer duration of corticosteroid use and disease-modifying anti-rheumatic drug (DMARD) use were independent predictors of bisphosphonate use. Use of respiratory medication was a negative predictor of bisphosphonate use. Conclusion: There has been a significant increase in osteoporosis prophylaxis in a population at high risk for osteoporosis/fractures. In particular, females appear reasonably well treated; however, men are still not receiving prevention to the same degree as women.

Original languageEnglish
Pages (from-to)1429-1433
Number of pages5
JournalOsteoporosis International
Volume18
Issue number10
DOIs
Publication statusPublished - 1 Oct 2007
Externally publishedYes

Fingerprint

Diphosphonates
Netherlands
Osteoporosis
Adrenal Cortex Hormones
Antirheumatic Agents
Pharmacies
Prednisolone
Multivariate Analysis
Logistic Models
Guidelines

Cite this

Duyvendak, M. ; Naunton, M. ; Atthobari, J. ; Van Den Berg, P. B. ; Brouwers, J. R.B.J. / Corticosteroid-induced osteoporosis prevention : Longitudinal practice patterns in The Netherlands 2001-2005. In: Osteoporosis International. 2007 ; Vol. 18, No. 10. pp. 1429-1433.
@article{fc19f0509b7243cf9c6b9ef012bdf42d,
title = "Corticosteroid-induced osteoporosis prevention: Longitudinal practice patterns in The Netherlands 2001-2005",
abstract = "Summary: We investigated prevention trends and predictors for osteoporosis prevention in long term corticosteroid users. The use of bisphosphonates increased from 2001 to 2005. Longer duration of corticosteroid use and DMARD use were predictors for receiving prevention. Females appear reasonably well treated; however, men require more attention. Introduction: Previous studies have shown that long-term corticosteroid users are undertreated for osteoporosis prevention. Our aim was to identify prevention trends in long-term corticosteroid users from 2001-2005 in The Netherlands and to identify predictors for bisphosphonate prophylaxis. Methods: Pharmacy dispensing data were used from 9 community pharmacies. All oral corticosteroid doses were converted to {"}prednisolone equivalents{"}. We then identified long-term (≥90 days) corticosteroid episodes, which required bisphosphonate prophylaxis as per 2002 Dutch guidelines; Multivariate logistic regression was used to identify predictors for receiving prevention. Results: We identified 615 different corticosteroid patients requiring prophylaxis. From 2001-2005 the use of bisphosphonates increased from 38{\%} to 54{\%} (p=0.001). In 2005 females were prescribed more bisphosphonates than males (61{\%} vs. 39{\%}; p=0.002), or any treatment (72{\%} vs. 45{\%}; p<0.001). Multivariate analysis showed that longer duration of corticosteroid use and disease-modifying anti-rheumatic drug (DMARD) use were independent predictors of bisphosphonate use. Use of respiratory medication was a negative predictor of bisphosphonate use. Conclusion: There has been a significant increase in osteoporosis prophylaxis in a population at high risk for osteoporosis/fractures. In particular, females appear reasonably well treated; however, men are still not receiving prevention to the same degree as women.",
keywords = "Corticosteroids, Osteoporosis, Prescribing patterns, Prevention, The Netherlands",
author = "M. Duyvendak and M. Naunton and J. Atthobari and {Van Den Berg}, {P. B.} and Brouwers, {J. R.B.J.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1007/s00198-007-0345-9",
language = "English",
volume = "18",
pages = "1429--1433",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer",
number = "10",

}

Corticosteroid-induced osteoporosis prevention : Longitudinal practice patterns in The Netherlands 2001-2005. / Duyvendak, M.; Naunton, M.; Atthobari, J.; Van Den Berg, P. B.; Brouwers, J. R.B.J.

In: Osteoporosis International, Vol. 18, No. 10, 01.10.2007, p. 1429-1433.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Corticosteroid-induced osteoporosis prevention

T2 - Longitudinal practice patterns in The Netherlands 2001-2005

AU - Duyvendak, M.

AU - Naunton, M.

AU - Atthobari, J.

AU - Van Den Berg, P. B.

AU - Brouwers, J. R.B.J.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Summary: We investigated prevention trends and predictors for osteoporosis prevention in long term corticosteroid users. The use of bisphosphonates increased from 2001 to 2005. Longer duration of corticosteroid use and DMARD use were predictors for receiving prevention. Females appear reasonably well treated; however, men require more attention. Introduction: Previous studies have shown that long-term corticosteroid users are undertreated for osteoporosis prevention. Our aim was to identify prevention trends in long-term corticosteroid users from 2001-2005 in The Netherlands and to identify predictors for bisphosphonate prophylaxis. Methods: Pharmacy dispensing data were used from 9 community pharmacies. All oral corticosteroid doses were converted to "prednisolone equivalents". We then identified long-term (≥90 days) corticosteroid episodes, which required bisphosphonate prophylaxis as per 2002 Dutch guidelines; Multivariate logistic regression was used to identify predictors for receiving prevention. Results: We identified 615 different corticosteroid patients requiring prophylaxis. From 2001-2005 the use of bisphosphonates increased from 38% to 54% (p=0.001). In 2005 females were prescribed more bisphosphonates than males (61% vs. 39%; p=0.002), or any treatment (72% vs. 45%; p<0.001). Multivariate analysis showed that longer duration of corticosteroid use and disease-modifying anti-rheumatic drug (DMARD) use were independent predictors of bisphosphonate use. Use of respiratory medication was a negative predictor of bisphosphonate use. Conclusion: There has been a significant increase in osteoporosis prophylaxis in a population at high risk for osteoporosis/fractures. In particular, females appear reasonably well treated; however, men are still not receiving prevention to the same degree as women.

AB - Summary: We investigated prevention trends and predictors for osteoporosis prevention in long term corticosteroid users. The use of bisphosphonates increased from 2001 to 2005. Longer duration of corticosteroid use and DMARD use were predictors for receiving prevention. Females appear reasonably well treated; however, men require more attention. Introduction: Previous studies have shown that long-term corticosteroid users are undertreated for osteoporosis prevention. Our aim was to identify prevention trends in long-term corticosteroid users from 2001-2005 in The Netherlands and to identify predictors for bisphosphonate prophylaxis. Methods: Pharmacy dispensing data were used from 9 community pharmacies. All oral corticosteroid doses were converted to "prednisolone equivalents". We then identified long-term (≥90 days) corticosteroid episodes, which required bisphosphonate prophylaxis as per 2002 Dutch guidelines; Multivariate logistic regression was used to identify predictors for receiving prevention. Results: We identified 615 different corticosteroid patients requiring prophylaxis. From 2001-2005 the use of bisphosphonates increased from 38% to 54% (p=0.001). In 2005 females were prescribed more bisphosphonates than males (61% vs. 39%; p=0.002), or any treatment (72% vs. 45%; p<0.001). Multivariate analysis showed that longer duration of corticosteroid use and disease-modifying anti-rheumatic drug (DMARD) use were independent predictors of bisphosphonate use. Use of respiratory medication was a negative predictor of bisphosphonate use. Conclusion: There has been a significant increase in osteoporosis prophylaxis in a population at high risk for osteoporosis/fractures. In particular, females appear reasonably well treated; however, men are still not receiving prevention to the same degree as women.

KW - Corticosteroids

KW - Osteoporosis

KW - Prescribing patterns

KW - Prevention

KW - The Netherlands

UR - http://www.scopus.com/inward/record.url?scp=34548592249&partnerID=8YFLogxK

U2 - 10.1007/s00198-007-0345-9

DO - 10.1007/s00198-007-0345-9

M3 - Article

VL - 18

SP - 1429

EP - 1433

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 10

ER -